Nippon Shinyaku Co Ltd represents strong values and a corporate philosophy centered on innovation, quality, and customer satisfaction. With a rich history and expertise in the healthcare industry, the company focuses on developing and providing high-quality pharmaceutical products to improve people's lives. Nippon Shinyaku Co Ltd is committed to conducting business ethically and contributing to society through its advanced research and development capabilities. With a customer-centric approach, the company aims to meet the diverse needs of individuals and continuously strive for excellence in all aspects of its operations.

Nippon Shinyaku Co Ltd is primarily present in Japan.

Nippon Shinyaku Co Ltd, a leading pharmaceutical company headquartered in Japan, has accomplished several significant milestones throughout its history. One notable achievement includes the development and launch of PLETAL® (cilostazol), an oral medication for the treatment of peripheral artery disease. Furthermore, the company attained success with the approval and commercialization of LIVALO® (pitavastatin), a statin medication used for managing cholesterol levels. Nippon Shinyaku Co Ltd also expanded its global presence through strategic partnerships and collaborations, fortifying its position in the international pharmaceutical market. With a commitment to innovation, research, and quality, the company continues to achieve remarkable milestones in the healthcare industry.

Nippon Shinyaku Co Ltd, founded in 1925, is a prominent Japanese pharmaceutical company specializing in the development and manufacturing of innovative medical solutions. With a rich history spanning over 95 years, Nippon Shinyaku has grown into a global leader in the healthcare industry. They are committed to enhancing human health and wellbeing through their cutting-edge research and development efforts. Nippon Shinyaku's diverse portfolio encompasses prescription drugs, diagnostic agents, and over-the-counter medicines, catering to various therapeutic areas. Their steadfast dedication to high-quality products, advanced technologies, and ethical practices has earned them a respected reputation in the pharmaceutical sector. Nippon Shinyaku continues to strive for excellence while contributing to the betterment of society through their innovative healthcare solutions.

The main competitors of Nippon Shinyaku Co Ltd in the market include large pharmaceutical companies such as Takeda Pharmaceutical Co Ltd, Astellas Pharma Inc, and Daiichi Sankyo Co Ltd. These companies operate in similar therapeutic areas and compete in the development and manufacturing of innovative pharmaceutical products. Nippon Shinyaku Co Ltd faces fierce competition in the market as it strives to establish its presence and gain market share against these formidable rivals.

Nippon Shinyaku Co Ltd is primarily active in the pharmaceutical industry.

Nippon Shinyaku Co Ltd is a pharmaceutical company based in Japan. With a strong focus on research and development, their business model revolves around developing and manufacturing innovative pharmaceutical products for various therapeutic areas. Nippon Shinyaku aims to improve the quality of life for patients by providing potential solutions and healthcare advancements. By leveraging their expertise, technological capabilities, and strategic partnerships, they strive to deliver high-quality, reliable, and effective medications. Nippon Shinyaku Co Ltd's commitment to innovation and dedication to meeting the healthcare needs of patients positions them as a trusted and prominent player in the pharmaceutical industry.

The Nippon Shinyaku Co P/E ratio is 9.09.

The Nippon Shinyaku Co P/S ratio is 1.58.

The AlleAktien quality score for Nippon Shinyaku Co is 8/10.

The Nippon Shinyaku Co revenue is 148.26 B JPY.

The Nippon Shinyaku Co profit is 25.85 B JPY.

Nippon Shinyaku Co. Ltd is a Japanese company that covers 9 business areas and specializes in the development, manufacture, and distribution of products in the pharmaceuticals, medical devices, dietary supplements, veterinary medicines, fine chemicals, cosmetics, diagnostic reagents, logistics, and real estate services sectors. In the pharmaceuticals sector, the company offers a wide range of medications for various therapeutic areas, such as cardiovascular diseases, oncological diseases, infectious diseases, and kidney diseases. Some of the well-known products include Clenafin, a medication for treating fungal infections, and Tarlige, a medication for treating cardiovascular diseases. In the medical devices sector, the company offers a wide range of products and services that encompass everything from the development to the marketing and use of medical devices. The company specializes particularly in imaging devices such as CT scanners, digital mammography systems, and ultrasound devices. In the dietary supplements sector, the company offers products for well-being and health. Products such as turmeric, which support digestion function, or essential nutrients such as vitamins, are offered. In the veterinary medicines sector, Nippon Shinyaku specializes in the development and marketing of veterinary medicines for pets. Some of the well-known products include dog medicines such as Traylix, a medication for anxiety in dogs. In the fine chemicals sector, the company manufactures a variety of chemical compounds for research and industry. The products include intermediates, fine chemical products, agrochemicals, chemical reagents, and pigments. In the cosmetics sector, Nippon Shinyaku specializes in the development of skincare products based on natural ingredients. The products include a wide range of skincare products such as cleansers, moisturizers, and anti-aging products. In the diagnostic reagents sector, the company manufactures specialized reagents used in laboratory tests. These reagents are used for diagnosing diseases and monitoring treatments. In addition, Nippon Shinyaku also offers logistics services such as storage, transportation, and distribution of pharmaceutical products. In real estate services, the company operates residential complexes and commercially-used buildings in Japan. Overall, the company has a diverse business portfolio and operates in various industries. Nippon Shinyaku is committed to improving the quality and effectiveness of its products and services through continuous research and development efforts.

Nippon Shinyaku Co pays a dividend of 116 JPY distributed over payouts per year.

The dividend cannot currently be calculated for Nippon Shinyaku Co or the company does not pay out a dividend.

The ISIN of Nippon Shinyaku Co is JP3717600005.

The WKN of Nippon Shinyaku Co is 858032.

The ticker of Nippon Shinyaku Co is 4516.T.

Over the past 12 months, Nippon Shinyaku Co paid a dividend of 124 JPY . This corresponds to a dividend yield of about 3.56 %. For the coming 12 months, Nippon Shinyaku Co is expected to pay a dividend of 135.5 JPY.

The current dividend yield of Nippon Shinyaku Co is 3.56 %.

Nippon Shinyaku Co pays a quarterly dividend. This is distributed in the months of October, April, October, April.

Nippon Shinyaku Co paid dividends every year for the past 23 years.

For the upcoming 12 months, dividends amounting to 135.5 JPY are expected. This corresponds to a dividend yield of 3.88 %.

Nippon Shinyaku Co is assigned to the 'Health' sector.

To receive the latest dividend of Nippon Shinyaku Co from 12/1/2024 amounting to 62 JPY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.

The last dividend was paid out on 12/1/2024.

In the year 2023, Nippon Shinyaku Co distributed 119 JPY as dividends.

The dividends of Nippon Shinyaku Co are distributed in JPY.